Cathie Wood's position in Veracyte is currently worth $151 Million. That's 1.11% of their equity portfolio (25th largest holding). The investor owns 12.71% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares fifteen more times and sold shares on five occasions. The investor's estimated purchase price is $233 Million, resulting in a loss of 35%.